| Background: | SLC6A14, also known as ATB0+, is a member of the Na+ - and Cl- - dependent neurotransmitter transporter family, and is highly expressed in the lung, fetal lung, trachea, and salivary gland. SLC6A14 transports both neutral and cationic amino acids, and has about 60% amino acid similarity with the glycine transporters GLYT1 and GLYT2. The blockade of ATB0+ in cancer cell lines is associated with cell cycle arrest, indicating the potential of ATB0+ as a drug target in cancer chemotherapy. |
| Clonality: | Polyclonal |
| Formulation: | In PBS/50% glycerol, pH 7.2 |
| Gene ID Human: | 11254 |
| Gene ID Mouse: | 56774 |
| Host Species: | Rabbit |
| Immunogen: | Human SLC6A14-derived synthetic peptide |
| Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
| Isotype: | IgG |
| Product Type: | Primary Antibody |
| Shipping: | 4 |
| Size: | 50 µL |
| Species Reactivities: | Human |
| Status: | RUO |
| Storage: | -20℃ |
| Target: | SLC6A14 |
Applications: FCM, IC, IH, WB
| FCM: | 1:1000 |
| ICC: | 1:1000 |
| IHC: | 1:5000 (Heat treatment is necessary for paraffin e |
| WB: | 1:1000 |
There are no references for Anti-SLC6A14 (ATB0+) (Human) pAb at this time.